Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dexcom Inc shares valued at $234,217 were sold by FOLETTA MARK G on Jul 15 ’25. At $85.17 per share, FOLETTA MARK G sold 2,750 shares. The insider’s holdings dropped to 53,871 shares worth approximately $4.53 million following the completion of this transaction.
Also, Brown Michael Jon sold 500 shares, netting a total of over 43,015 in proceeds. Following the sale of shares at $86.03 each, the insider now holds 94,602 shares.
Before that, MICHAEL BROWN had added 500 shares to its account. In a trade valued at $43,015, the Officer bought Dexcom Inc shares for $86.03 each.
As published in their initiating research note from Truist on June 16, 2025, Dexcom Inc [DXCM] has been a Buy and the price target has been revised to $102. Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in late May. As of April 10, 2025, Mizuho has initiated its “an Outperform” rating for DXCM. Earlier on February 03, 2025, Redburn Atlantic upgraded its rating. Their new recommendation was “a Buy” for DXCM stock which previously was a “a Neutral”.
Analyzing DXCM Stock Performance
On last trading session,, Dexcom Inc [NASDAQ: DXCM] plunged -0.04% to $84.1. The stock’s lowest price that day was $83.54, but it reached a high of $85.9 in the same session. During the last five days, there has been a drop of approximately -1.59%. Over the course of the year, Dexcom Inc shares have dropped approximately -25.58%.
Support And Resistance Levels for Dexcom Inc (DXCM)
RSI (Relative Strength Index) is 50.47 on the 14-day chart, showing neutral technical sentiment.
Is Dexcom Inc subject to short interest?
Stocks of Dexcom Inc saw a sharp steep in short interest on 2025-06-13 dropping by -1.9 million shares to 9.38 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 11.28 million shares. A decline of -20.31% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.29 of the overall float, the days-to-cover ratio (short ratio) decline to 3.29.
Which companies own the most shares of Dexcom Inc (DXCM)?
In terms of Dexcom Inc share price expectations, FactSet research, analysts set an average price target of 95 in the next 12 months, up nearly 12.92% from the previous closing price of $84.13. Analysts anticipate Dexcom Inc stock to reach 146 by 2025, with the lowest price target being 28.125. In spite of this, 12 analysts ranked Dexcom Inc stock as Buy at the end of 2025. On January 16, 2025, Robert W. Baird assigned a price target of “an Outperform” to the stock and upgraded coverage with a $104.
